Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
60 participants
INTERVENTIONAL
2022-09-01
2023-12-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators aim to compare the treatment response at 1 and 3 months between two patient groups treated with both methods. For this purpose, The investigators planned to follow up with 60 patients. GON RF will be performed with a proximal approach to half of the patients and a distal approach to the other half. Pain levels will be measured on the Visual Analogue Scale (VAS) in the 1st and 3rd months after the procedure. Migraine Disability Index (MIDAS) will be applied to the patients in the 1st week and 3rd month after the procedure. Thus, it will be determined whether there is a difference between the approaches in terms of pain palliation.
Patients who have undergone the procedure will be found from their file records and called by phone, when they come to the control, face to face and 1-3. In the months, the scales will be filled by calling by phone.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Proximal block
GON block is performed at C2 vertebra level
Greater occipital nerve radiofrequency
Greater nerve block and radiofrequency will be performed at the C2 vertebra level or occipital protuberance
Distal block
GON block is performed at occipital protuberence
Greater occipital nerve radiofrequency
Greater nerve block and radiofrequency will be performed at the C2 vertebra level or occipital protuberance
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Greater occipital nerve radiofrequency
Greater nerve block and radiofrequency will be performed at the C2 vertebra level or occipital protuberance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Diskapi Teaching and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Damla Yürük
director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Damla Yuruk
Role: STUDY_DIRECTOR
Diskapi TRH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Diskapi Training and Research Hospital
Ankara, , Turkey (Türkiye)
Dişkapi Reserch and Education Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GONRFT
Identifier Type: -
Identifier Source: org_study_id